We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Predictive medicine company IMI International Medical Innovations will initiate
a new clinical trial to evaluate the relationship between skin sterol values
and a variety of new and established coronary artery disease markers, including
ankle/brachial blood pressure index and vascular compliance, in high-risk patients.
Artes Medical, a privately held specialty pharmaceutical and medical device
company, announced the U.S. Patent and Trademark Office granted its request
for reexamination of the Aventis patent that covers injectable skin fillers
using poly-lactic-acid microspheres, marketed in the U.S. under the Sculptra
trademark and in Europe as New-Fill.
DiaSys, a global diagnostics products company, has executed a letter of intent
to acquire all of the outstanding capital stock of Biocheck and EverNew Biotech,
both headquartered in Foster City, Calif. Biocheck develops, manufactures and
distributes immunodiagnostic test kits for the worldwide healthcare markets.
Life Medical Sciences has announced that a planned interim analysis of patient
data from its REPEL-CV pivotal clinical trial was completed by a data and safety
monitoring board (DSMB) comprised of medical and biostatistical specialists
who are not participating in this clinical trial.
RetinaPharma Technologies has announced FDA clearance
to market its proprietary TonoPach that enables more accurate diagnosis of glaucoma
and ocular hypertension, leading causes of preventable blindness among adults.
Imalux, a medical device company and developer of the Niris Imaging System based
on Optical Coherence Tomography (OCT) technology, has announced that the Niris
System received market clearance from the FDA.
Eden Prairie, Minn-based Inlet Medical, a medical device company that develops
and markets specialty laparoscopic surgical products, launched the Carter-Thomason
CloseSure System XL for trocar wound closure designed especially for obese and
bariatric patients to prevent port-site herniation.
Smith & Nephew's Endoscopy division has launched the GTS System for use
in arthroscopic soft tissue reconstruction of the anterior cruciate ligament
(ACL) in the knee.
ProRhythm, a developer and manufacturer of medical devices for the treatment
of atrial fibrillation (AF), has entered into a number of agreements with St.
Jude Medical.